| STRUCTURE |
5-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl-1-methyl-1H-p- yrrole-2-carbonitrile. |
| CLINICAL STUDY | Phase II |
| INDICATION'S | Gynecology>Oral Contraception |
| MECHANISM OF ACTION | Non-Steroid Progesterone Receptor Agonist |
| SIDE EFFECT'S | Fewer than Steroids |
| STATUS | US Patent Expiration Date: 04.19.2020 |
| UPDATE | 08.04 |
| COMPANY | This data is not available for free |
| LITERATURE REF. | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |